Logo image of APPN

APPIAN CORP-A (APPN) Stock Fundamental Analysis

NASDAQ:APPN - Nasdaq - US03782L1017 - Common Stock - Currency: USD

33.34  -1.29 (-3.73%)

After market: 33.2188 -0.12 (-0.36%)

Fundamental Rating

2

Overall APPN gets a fundamental rating of 2 out of 10. We evaluated APPN against 283 industry peers in the Software industry. Both the profitability and financial health of APPN have multiple concerns. APPN is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

APPN had negative earnings in the past year.
APPN had a positive operating cash flow in the past year.
In the past 5 years APPN always reported negative net income.
APPN had negative operating cash flow in 4 of the past 5 years.
APPN Yearly Net Income VS EBIT VS OCF VS FCFAPPN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M

1.2 Ratios

APPN's Return On Assets of -14.86% is on the low side compared to the rest of the industry. APPN is outperformed by 67.75% of its industry peers.
Industry RankSector Rank
ROA -14.86%
ROE N/A
ROIC N/A
ROA(3y)-19.34%
ROA(5y)-16.42%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
APPN Yearly ROA, ROE, ROICAPPN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200 -200

1.3 Margins

APPN's Gross Margin of 75.66% is fine compared to the rest of the industry. APPN outperforms 69.57% of its industry peers.
In the last couple of years the Gross Margin of APPN has grown nicely.
APPN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 75.66%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.76%
GM growth 5Y3.42%
APPN Yearly Profit, Operating, Gross MarginsAPPN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

2

2. Health

2.1 Basic Checks

APPN does not have a ROIC to compare to the WACC, probably because it is not profitable.
APPN has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, APPN has more shares outstanding
The debt/assets ratio for APPN is higher compared to a year ago.
APPN Yearly Shares OutstandingAPPN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
APPN Yearly Total Debt VS Total AssetsAPPN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

APPN has an Altman-Z score of 1.74. This is a bad value and indicates that APPN is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of APPN (1.74) is comparable to the rest of the industry.
APPN has a debt to FCF ratio of 81.31. This is a negative value and a sign of low solvency as APPN would need 81.31 years to pay back of all of its debts.
The Debt to FCF ratio of APPN (81.31) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 81.31
Altman-Z 1.74
ROIC/WACCN/A
WACC14.1%
APPN Yearly LT Debt VS Equity VS FCFAPPN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

2.3 Liquidity

A Current Ratio of 1.23 indicates that APPN should not have too much problems paying its short term obligations.
APPN has a worse Current ratio (1.23) than 65.22% of its industry peers.
APPN has a Quick Ratio of 1.23. This is a normal value and indicates that APPN is financially healthy and should not expect problems in meeting its short term obligations.
APPN's Quick ratio of 1.23 is on the low side compared to the rest of the industry. APPN is outperformed by 64.86% of its industry peers.
Industry RankSector Rank
Current Ratio 1.23
Quick Ratio 1.23
APPN Yearly Current Assets VS Current LiabilitesAPPN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 56.25% over the past year.
APPN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.15%.
The Revenue has been growing by 18.83% on average over the past years. This is quite good.
EPS 1Y (TTM)56.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)13.15%
Revenue growth 3Y18.66%
Revenue growth 5Y18.83%
Sales Q2Q%14.71%

3.2 Future

APPN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 46.51% yearly.
Based on estimates for the next years, APPN will show a quite strong growth in Revenue. The Revenue will grow by 14.21% on average per year.
EPS Next Y136.47%
EPS Next 2Y92.93%
EPS Next 3Y82.81%
EPS Next 5Y46.51%
Revenue Next Year11.07%
Revenue Next 2Y11.21%
Revenue Next 3Y13.5%
Revenue Next 5Y14.21%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
APPN Yearly Revenue VS EstimatesAPPN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 500M 1B 1.5B
APPN Yearly EPS VS EstimatesAPPN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 1 -1 2 3

1

4. Valuation

4.1 Price/Earnings Ratio

APPN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 261.22 indicates a quite expensive valuation of APPN.
Compared to the rest of the industry, the Price/Forward Earnings ratio of APPN indicates a slightly more expensive valuation: APPN is more expensive than 62.32% of the companies listed in the same industry.
APPN is valuated expensively when we compare the Price/Forward Earnings ratio to 22.70, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 261.22
APPN Price Earnings VS Forward Price EarningsAPPN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 200

4.2 Price Multiples

The rest of the industry has a similar Price/Free Cash Flow ratio as APPN.
Industry RankSector Rank
P/FCF 799.83
EV/EBITDA N/A
APPN Per share dataAPPN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as APPN's earnings are expected to grow with 82.81% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y92.93%
EPS Next 3Y82.81%

0

5. Dividend

5.1 Amount

APPN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

APPIAN CORP-A

NASDAQ:APPN (2/21/2025, 8:01:29 PM)

After market: 33.2188 -0.12 (-0.36%)

33.34

-1.29 (-3.73%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-19 2025-02-19/bmo
Earnings (Next)04-30 2025-04-30/amc
Inst Owners74.4%
Inst Owner Change-93.28%
Ins Owners5.91%
Ins Owner Change55%
Market Cap2.46B
Analysts53.85
Price Target41.14 (23.4%)
Short Float %4.09%
Short Ratio4.26
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)186.51%
Min EPS beat(2)100%
Max EPS beat(2)273.01%
EPS beat(4)3
Avg EPS beat(4)85.82%
Min EPS beat(4)-47.52%
Max EPS beat(4)273.01%
EPS beat(8)7
Avg EPS beat(8)63.62%
EPS beat(12)9
Avg EPS beat(12)40.02%
EPS beat(16)11
Avg EPS beat(16)34.46%
Revenue beat(2)0
Avg Revenue beat(2)-0.54%
Min Revenue beat(2)-0.57%
Max Revenue beat(2)-0.51%
Revenue beat(4)1
Avg Revenue beat(4)-0.64%
Min Revenue beat(4)-1.91%
Max Revenue beat(4)0.44%
Revenue beat(8)4
Avg Revenue beat(8)-0.06%
Revenue beat(12)7
Avg Revenue beat(12)0.64%
Revenue beat(16)10
Avg Revenue beat(16)1.53%
PT rev (1m)-1.63%
PT rev (3m)-0.17%
EPS NQ rev (1m)-400.75%
EPS NQ rev (3m)86.55%
EPS NY rev (1m)5.59%
EPS NY rev (3m)-25.77%
Revenue NQ rev (1m)0.01%
Revenue NQ rev (3m)-1.64%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.23%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 261.22
P/S 3.99
P/FCF 799.83
P/OCF 358.17
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.35
EYN/A
EPS(NY)0.13
Fwd EY0.38%
FCF(TTM)0.04
FCFY0.13%
OCF(TTM)0.09
OCFY0.28%
SpS8.35
BVpS-0.44
TBVpS-0.82
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -14.86%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 75.66%
FCFM 0.5%
ROA(3y)-19.34%
ROA(5y)-16.42%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.76%
GM growth 5Y3.42%
F-Score7
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 81.31
Debt/EBITDA N/A
Cap/Depr 37.87%
Cap/Sales 0.62%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.23
Quick Ratio 1.23
Altman-Z 1.74
F-Score7
WACC14.1%
ROIC/WACCN/A
Cap/Depr(3y)88.09%
Cap/Depr(5y)78.24%
Cap/Sales(3y)1.44%
Cap/Sales(5y)1.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)56.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
EPS Next Y136.47%
EPS Next 2Y92.93%
EPS Next 3Y82.81%
EPS Next 5Y46.51%
Revenue 1Y (TTM)13.15%
Revenue growth 3Y18.66%
Revenue growth 5Y18.83%
Sales Q2Q%14.71%
Revenue Next Year11.07%
Revenue Next 2Y11.21%
Revenue Next 3Y13.5%
Revenue Next 5Y14.21%
EBIT growth 1Y49.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1055.68%
EBIT Next 3Y196.37%
EBIT Next 5Y104.01%
FCF growth 1Y102.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y106.23%
OCF growth 3YN/A
OCF growth 5YN/A